Skip to content
Screener

Rivian Automotive, Inc. RIVN Testing Milestone Payments — Receivable, contingent on milestone achievement

Similar metrics at other companies

Climb Bio, Inc. logo
CLYMSales Milestones — Milestone Payments
$8M
Tarsus Pharmaceuticals, Inc. logo
TARSSales-based Milestones — Maximum milestone payments
$4M
Tarsus Pharmaceuticals, Inc. logo
TARSCommercial and Sales Milestones — Maximum milestone payments
$77M0.0%
Tarsus Pharmaceuticals, Inc. logo
TARSClinical Milestones — Contractual milestone payment net sales
$500K
Evolus logo
EOLSContingent milestone payment
$1.54M-42.4%
Savara logo
SVRANebulizer — Contingent Milestone Payments
$573K+5.9%

Other financials

Income statement

See full
Revenue$1.7B+27.2%
Gross profit$119.0M-42.2%
Operating income-$881.0M-34.5%
Net income-$833.0M+25.4%
EPS (diluted)-$0.63+35.1%

Balance sheet

See full
Cash & equivalents$2.8B-39.4%
Total debt$5.2B+7.5%
Total equity$4.4B-28.9%
Total assets$14.2B-8.2%

Cash flow

See full
Operating cash flow-$703.0M-274%
CapEx$372.0M+10.1%
Free cash flow-$1.1B-104%

Valuation

See full
Market cap$22.53B+59.5%
Enterprise value$24.92B+47.8%
P/S3.8×+1.1×

Profitability

See full
Gross margin1%
Operating margin-68.9%-6.6pp
Net margin-55%-8.9pp
FCF margin-55%

Returns & leverage

See full
Return on equity-66%+19.4pp
Debt / equity1.2×+0.4×
Current ratio2.1×-1.6×

Where this comes from

Reported directly by Rivian Automotive, Inc. in its filing.

Tagged under the XBRL concept rivn:ReceivableContingentOnMilestoneAchievement.

The source filing: Rivian Automotive, Inc.’s 10-K, filed February 12, 2026.

Filed
Feb 12, 2026, 5:01 PM EST
Fiscal year
FY2025
Accession
0001874178-26-000008
  • As of March 31, 2025 the Financial Milestone was achieved, and on June 30, 2025 the Company received $1,000 million in exchange for $750 million of the Company’s class A common stock, equal to approximately 52 million shares at a price of $14.56 per share, with deferred revenues recorded within “Current portion of deferred revenues, lease liabilities, and other liabilities” and “Other non-current liabilities” on the Consolidated Balance Sheets for the $250 million premium received. As a result of the transaction, Volkswagen Group became a related party of the Company on June 30, 2025. See Note 4 "Revenues" for more information on deferred revenues and Note 14 "Related Party Transactions".
  • Upon achievement of the Testing Milestones defined in the Investment Agreement, the Company will receive $1,000 million in exchange for $1,000 million of the Company’s class A common stock, calculated based on the Company’s 30-trading day volume-weighted average price prior to share issuance (although the aggregate share issuance may be effected through convertible note mechanisms or in stages).

Item 8. Financial Statements and Supplementary Data

FAQ

What is Rivian Automotive, Inc.'s testing milestone payments — receivable, contingent on milestone achievement?
Rivian Automotive, Inc. (RIVN) reported testing milestone payments — receivable, contingent on milestone achievement of $1B in Q4 2025.
What does testing milestone payments — receivable, contingent on milestone achievement mean?
The value of payments or assets due to the company that are strictly dependent upon the successful completion of specific technical or operational milestones within the testing segment. This represents a form of performance-based revenue or capital inflow that is not yet guaranteed. It highlights the financial risk and potential upside associated with the segment's development progress.

Ask your AI about Rivian Automotive, Inc.'s testing milestone payments — receivable, contingent on milestone achievement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude